Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes - The NSABP study of tamoxifen and raloxifene (STAR) P-2 trial Article

Vogel, Victor G, Costantino, Joseph P, Wickerham, D Lawrence et al. (2006). Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes - The NSABP study of tamoxifen and raloxifene (STAR) P-2 trial . JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 295(23), 2727-2741. 10.1001/jama.295.23.joc60074

International Collaboration

cited authors

  • Vogel, Victor G; Costantino, Joseph P; Wickerham, D Lawrence; Cronin, Walter M; Cecchini, Reena S; Atkins, James N; Bevers, Therese B; Fehrenbacher, Louis; Pajon, Eduardo R; Wade, James L; Robidoux, Andre; Margolese, Richard G; James, Joan; Lippman, Scott M; Runowicz, Carolyn D; Ganz, Patricia A; Reis, Steven E; McCaskill-Stevens, Worta; Ford, Leslie G; Jordan, V Craig; Wolmark, Norman

sustainable development goals

authors

publication date

  • June 21, 2006

webpage

published in

keywords

  • BONE-MINERAL DENSITY
  • ESTROGEN-RECEPTOR MODULATORS
  • General & Internal Medicine
  • HEALTH SURVEY SF-36
  • Life Sciences & Biomedicine
  • MULTIPLE OUTCOMES
  • Medicine, General & Internal
  • PATIENT
  • POSTMENOPAUSAL WOMEN
  • PREVENTION
  • RANDOMIZED-TRIAL
  • REDUCTION
  • SURGICAL ADJUVANT BREAST
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • AMER MEDICAL ASSOC

start page

  • 2727

end page

  • 2741

volume

  • 295

issue

  • 23